Susanna Gaikazian, MD has joined Florida Cancer Specialists & Research Institute.
Fort Myers, Fla., July 18, 2022 – Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified medical oncologist Susanna Gaikazian, MD to the statewide practice. She is providing care to patients at the FCS Estero clinic at 8440 Murano Del Lago Drive, Estero, Florida 34135 and at the FCS Fort Myers Colonialclinic at 8931 Colonial Center Drive, Suite 300, Fort Myers, Florida 33905.
Dr. Gaikazian has more than ten years of oncology experience with a special focus on treating a wide variety of solid tissue tumors, hematologic malignancies and benign hematologic disorders. Active in clinical research, her abstracts have been widely published and she is a frequent presenter at professional forums including ASCO Genitourinary Cancers Symposium (ASCO-GU), the American Society of Hematology Annual Meeting (ASH) and Oakland University William Beaumont Hospital School of Medicine. Dr. Gaikazian received her medical degree from Yerevan State Medical University in Yerevan, Armenia. She completed a residency in Internal Medicine and a fellowship in Hematology/Oncology at Henry Ford Health System in Detroit, Michigan.
“The role our physicians play in the advancement of oncology care through research is an essential part of our mission at FCS, to be “powered by science and innovation.” Dr. Gaikazian will be a great contributor to the research conducted in Lee County. Already, she shares our commitment to ensuring patients have convenient access to world-class cancer care, close to home. We are very pleased to welcome her to our practice,” said FCS Chief Executive Officer Nathan H. Walcker.
FCS President & Managing Physician Michael Diaz, MD said, “Dr. Gaikazian’s specialized expertise in treating hematologic disorders and malignancies will further enhance the range of treatment options for our patients in Lee County.”
###
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
For More Information, Contact:
Michelle Robey, VP of Marketing
Michelle.Robey@FLCancer.com
(813) 767-9398
Jennifer Bradley, Director of Corporate Communications
Jennifer.Bradley@FLCancer.com
(847) 280-1740
Petosemtamab and Pembrolizumab: A Promising Pair in HNSCC Treatment
July 2nd 2024In an interview, Cesar Augusto Perez, MD, delved into the findings from a phase 2 study evaluating petosemtamab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Read More